Investors
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
We have released our Fourth Quarter and Full Year 2023 results 2023 trading results.
We will release our first quarter 2024 results on Wednesday 1 May 2024 at 07:00am BST.
Conference call and webcast
There will be a conference call for financial analysts at 08:30am GMT, which will be webcast live at the link below
Event details:
The Annual General Meeting of Smith & Nephew plc will be held at 12:00pm on Wednesday, 1 May 2024 at Smith+Nephew Academy London, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE.
As a portfolio medical technology company, Smith+Nephew’s purpose is to restore and promote health and wellbeing.
We believe that this applies not just to the benefits our products deliver to patients, but also to the wider health of the planet and society.